(7-9), neuroblastomas (10), small cell lung carcinomas (11), leukaemias and lymphomas (12), and induction of apoptotic The cancer chemopreventive synthetic retinoid N-(4-cell death at doses which are achievable pharmacologically hydroxyphenyl)retinamide (HPR) possesses antiprolifera-(10-12). Recently, we have shown that cell killing by HPR is tive and apoptotic activity at pharmacological doses. In strongly antagonized by deregulated expression of the antithis study we show that addition of antioxidants to HL-60 apoptotic gene bcl-2 as well as by certain antioxidants (13). cells cultured in the presence of 3 µM HPR, markedly
Introduction

Materials and methods
N-(4-hydroxyphenyl)retinamide (HPR*) is a synthetic retinoic
Cell line and reagents acid derivative with cancer chemopreventive and therapeutic
The myeloid leukaemia cell line HL-60 , mycoplasma free, was grown in RPMI-1640 (Bio-Wittaker, Walkersville, MD) plus 10% heat-inactivated activities in experimental systems (1) . Studies in animals fetal calf serum (Irvine Scientific, Santa Ana, CA), 100 U/ml penicillin, have shown that HPR significantly inhibits the incidence of 100 µg/ml streptomycin, and 2 mmol/l glutamine. HPR and N-(4-methoxycarcinogen-induced mammary and urinary bladder lesions, phenyl)retinamide (MPR) were a gift of RW Johnson Pharmaceutical Research induces complete regression of transplanted tumours, and even Institute, Springhouse, PA. All-trans retinoic acid (ATRA) was from Sigma (St Louis, MO), whereas the retinoids 9-cis-retinoic acid (9-cis-RA), potentiates the activity of cisplatin (1-3). Cancer Institute are ongoing in our Institute to establish the Ϫ20°C, were always prediluted 1:10 in foetal calf serum prior to further dilutions in culture media. The antioxidants N-acetyl-L-cysteine (NAC), Lascorbic acid (VIT-C), α-tocopherol (VIT-E), deferoxamine (DFX) (all from *Abbreviations: HPR, N-(4-hydroxyphenyl)retinamide; MPR, N-(4-methoxyphenyl)retinamide; RAR, retinoic acid receptor; RXR, retinoid X receptor; Sigma), were used at maximal, non-cytotoxic doses, determined previously by a 72 h dose-response analysis. In assays involving multiple treatments, TTNPB,(E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-impropenyl] benzoic acid; ATRA, all-trans retinoic acid; 9-cis RA, 9-cis the antioxidants were added to cells 3 h before addition of other compounds. Viable cells were quantitated on trypan blue stained suspensions using a retinoic acid; DCF-DA, 2Ј,7Ј-dichlorofluorescin diacetate; DHR, dihydrorhodamine 123; VIT-C, L-ascorbic acid ; VIT-E, α-tocopherol; NAC, N-acetylhaemocytometer. Discrimination between apoptotic and necrotic cells was achieved by dual fluorescence microscopy analysis on samples stained with L-cysteine; DFX, deferoxamine.
5 µg/ml of the DNA-specific supravital dye Hoechst-33342 (Calbiochem, San of intracellular oxidised compound, can also be measured Diego, CA) (30 min at 37°C) and with 10 µg/ml propidium iodide (Sigma) in individual cells by flow cytometry (14, 20, 21 (Table I and Figure 1 ). To determine whether treated cells proportionally increased with increasing the dose antioxidants block or simply delay the action of HPR, we have of the oxidant above 1 µM ( Figure 3A) . When comparing the MFI values of these dose-response analysis, the intracellular analysed these effects over a longer period of time. As shown oxidation elicited by 3 µM HPR was equal to that caused by in Figure 2 , while only 5% of the cells remained alive after 100 µM H 2 O 2 ( Figure 3A ). 48 h of treatment with HPR, at the same time point the cells
To determine whether the ability to elicit intracellular incubated with HPR plus VIT-C were mostly alive, and actually oxidants was unique to HPR, other retinoids were also investitheir number increased almost 3-fold, relative to the number gated. In particular the retinamide derivative MPR, which is of seeded cells. By 72 h, however, the protective effect of also the major inert biological metabolite of HPR and is VIT-C against HPR was no longer effective, as evidenced by ineffective in triggering cell death (13), ATRA and 9-cis-RA, the sharp drop of cell viability. To ascertain whether this was two promoters of HL-60 cell differentiation (22) , TTNPB and due to the antioxidant activity of VIT-C being consumed, cells SR11237, two retinoids highly selective for RAR and RXR, were replenished, after 48 h of treatment with HPR plus VITrespectively (23). Unlike HPR, however, none of these retinoids C, with fresh VIT-C and kept in culture for another 48 h modified the fluorescence of DCF-DA-loaded cells when used before being analysed. Remarkably, the survival of these cells at 3 µM, as well as 15 µM in the case of MPR (to compensate for was significantly enhanced (Figure 2, empty column) , resulting, its lower intracellular uptake; DD, unpublished observation), at 96 h in a 6-fold higher cell number, relative to cells that clearly indicating that formation of free radicals may strictly had not been replenished with VIT-C. Also NAC antagonized depend on the structural features of the retinoid. the toxic effect of HPR, though less markedly than VIT-C, Remarkably, the increment of HPR-induced DCF-DA fluorresulting in a 2-fold increase in viable cell counts at 24 h, escence was completely blocked by VIT-C and NAC (Table which gradually declined thereafter. Together, these results II and Figure 4B ), strongly suggesting that these antioxidants emphasize the role of antioxidants in suppressing cell death intercept and neutralise the retinoid-elicited free radicals, by HPR.
which would otherwise oxidise DCF-DA. However, VIT-E, an Intracellular oxidants are induced upon treatment with HPR antioxidant reactive with hydrophobic radicals, did not prevent the HPR-induced intracellular oxidation of DCF-DA. DFX, The protection afforded by antioxidants against cell death by which inhibits the iron redox cycling (24) , partially suppressed HPR suggests that free radicals may be involved in this HPR-induced oxidation of DCF-DA. phenomenon. To verify this possibility, we examined the levels of intracellular free radicals before and after exposure to HPR Discussion using the cell permeant dyes DCF-DA and DHR, which become highly fluorescent after oxidation. The fluorescence
The retinoic acid derivative HPR has remarkable cancer chemopreventive and therapeutic activity in animal systems of these dyes, which increases proportionally with the amount Fig. 1 . Flow cytometric DNA analysis. The histograms were generated from the analysis of cells pre-treated for 3 h with (or without, for controls) the antioxidants, then incubated for 24 h with 3 µM HPR and subsequently stained with propidium iodide, as reported in Materials and methods. The subdiploid peak left of G1 is generated by cells containing fragmented DNA, whose percentage is indicated.
Table I. Inhibition of HPR-induced cell death by antioxidants
Compound Apoptosis inhibition VIT-C 100 µM 9 7 Ϯ 3% NAC 10 mM 89 Ϯ 6% VIT-E 1 mM 95 Ϯ 4% DFX 10 µM 9 1 Ϯ 6% HL-60 cells were pre-treated for 3 h with (or without, for control) the indicated doses of antioxidants prior to addition of 3 µM HPR and incubation for 24 h. Following staining with propidium iodide, as indicated in Materials and methods, the cells were examined by flow cytometry (10 000 events per sample) to quantitate cells with subdiploid, apoptotic DNA. Apoptotic cells in samples treated with HPR alone were 75 Ϯ 12%. Numbers denote the percentage protection Ϯ SD afforded by the individual compounds, and were obtained from not less than three independent experiments. Fig. 2 . Effect of antioxidants on the survival of HPR-treated cells. Samples were pre-incubated (or not, for controls) for 3 h with 100 µM VIT-C or 10 mM NAC, then treated with 3 µM HPR and examined every (1-3), and is currently being evaluated for the prevention of action remains unclear. We and others have recently shown that HPR possesses growth-inhibitory as well as apoptosisinducing activities at doses achievable pharmacologically (10-(13) , arguing that HPR responses and ultimately apoptosis involve the activation of an oxidative pathway. 12), thus suggesting that the therapeutic efficacy of HPR is linked to these functions (25) . More recently, we have shown
In this study, we have shown that antioxidants significantly prolong the survival of cells exposed to HPR by at least 48-that HPR-induced cell death is antagonised by deregulated levels of the anti-apoptotic gene bcl-2 and by antioxidants 72 h, thus suggesting the involvement of an oxidative pathway in this type of cell death. In this regard, it is worth noting that While this result presumably reflects the limited specificity of the DCF-DA indicator for water-soluble reactive oxygen an oxidative pathway may be involved in cell death elicited by cytokines or by conditions of trophic factor deprivation, as species (28) , nevertheless the fact that Vit-E suppresses the biological activity of HPR, most likely through its capacity to demonstrated by experiments with various antioxidants (15, 26) . Nevertheless, not all forms of cell death involve an oxidative intercept peroxyl radicals and so terminate lipid peroxidation reactions, particularly damaging to membranes and recently pathway, as in the case of FAS-induced apoptosis (27) . It is important to note that the suppressed biological activity of implicated in apoptotic events (29, 30) , suggests the possibility that HPR-elicited free radicals cause cell death by inducing HPR by the antioxidants is not the result of a diminished uptake of HPR, since comparable levels of retinoid in cells oxidative membrane damage. It is worth noting that the results described in this study, exposed or not to the antioxidants are detected by HPLC analysis (DD, unpublished) .
obtained by the use of the HL-60 cell line, were also observed in several other human leukemia and lymphoma cell lines, Taking advantage of DCF-DA and DHR, which become brightly fluorescent after oxidation (14, 20, 21) , we have demonincluding the RAR-defective and ATRA-unresponsive cell lines HL-60R and NB4-306 (DD, not shown), thus implying strated in cells treated with HPR the formation of free radicals, detectable after 10 min of treatment, at a time when the amount that oxidative stress is a common, cell-type and retinoidreceptor independent event in HPR response. of intracellular HPR accounts for 70% of the plateau level (13) . Importantly, neither the structurally related retinamide Thus far, the mechanism by which HPR evokes free radicals remains unknown, but currently we cannot exclude MPR, which is also a biologically inert metabolite of HPR (8,13), nor ATRA, 9-cis-RA, TTNPB or SR11273, four the possibility that HPR itself is metabolised to a free radical, or that it somehow interferes with the intracellular pathway retinoids with different selectivities for RAR and RXR molecules, and whose biological effects differ from those elicited responsible for maintaining the oxidant-antioxidant balance. In summary, we have shown, for the first time, that HPR by HPR (13, 22, 23) , induce the formation of free radicals. Additionally, we have shown that the oxidation of DCF-DA elicits the rapid and sustained formation of intracellular oxidants, most likely water-soluble free radicals, whose detoxificain cells treated with HPR is blocked by the water-soluble antioxidants NAC and VIT-C, and to a less extent by DFX, tion by antioxidants blocks the apoptotic activity of the retinoid. This finding, together with molecular data showing that HPR strongly suggesting these molecules antagonise cell death by neutralising free radicals. It should be noted, however, that is an activator of retinoid receptors (9,19), supports the view that HPR has two main modes of action, one retinoid-receptor the lipophilic chain-breaking antioxidant Vit-E fails to block the intracellular oxidation of DCF-DA in response to HPR. independent and associated with induction of free radicals and in vivo remains to be elucidated.
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